Keith D. Kaufman
Merck & Co., Inc., Rahway, NJ, USA (United States) · 142 works · 12,871 citations · h-index 55
Top works
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- Finasteride in the treatment of men with androgenetic alopecia
- Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor
- Metabolic Syndrome: A Clinical and Molecular Perspective
- Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
- Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
- Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1mg Treatment of Men and Postmenopausal Women
- Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
- Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.
- Measurement characteristics of a voiding diary for use by men and women with overactive bladder
- Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
- Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
- ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
- Finasteride increases anagen hair in men with androgenetic alopecia
- Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
- Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
- Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
- Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
- Androgens and alopecia
- CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN